Both in Pharmaceuticals
Parabilis Medicines vs AbCellera Biologics
Over the past year PBLS returned −38.3% and ABCL returned +8.4%; their daily moves had a correlation of 0.53.
PBLS −38.3% ABCL +8.4%Growth of $1, one year, split-adjusted
| Metric | PBLS | ABCL |
|---|---|---|
| Price | $22.75 | $11.80 |
| Market cap | $2.81B | $3.82B |
| Today | −9.65% | −6.94% |
| 1 month | −44.3% | −7.3% |
| 6 months | — | +194.3% |
| Year to date | — | +245.0% |
| 1 year | — | +93.4% |
| Revenue growth (YoY) | — | −76.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −45239.9% | −1368.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 57.8× |
| Net cash | $1.11B | $540.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 93.8% |
| Short % of float | 8.2% | 15.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).